5.94
+0.22(+3.85%)
Currency In USD
| Previous Close | 5.72 |
| Open | 5.7 |
| Day High | 6 |
| Day Low | 5.7 |
| 52-Week High | 8.9 |
| 52-Week Low | 3.68 |
| Volume | 98,762 |
| Average Volume | 259,921 |
| Market Cap | 219.93M |
| PE | -10.61 |
| EPS | -0.56 |
| Moving Average 50 Days | 6.93 |
| Moving Average 200 Days | 5.88 |
| Change | 0.22 |
If you invested $1000 in Lifecore Biomedical, Inc. (LFCR) 10 years ago, it would be worth $421.58 as of February 05, 2025 at a share price of $5.94. Whereas If you bought $1000 worth of Lifecore Biomedical, Inc. (LFCR) shares 5 years ago, it would be worth $516.07 as of February 05, 2025 at a share price of $5.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
GlobeNewswire Inc.
Feb 03, 2025 12:00 PM GMT
CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 B
Lifecore Biomedical Announces Special Stockholder Meeting
GlobeNewswire Inc.
Jan 17, 2025 10:24 PM GMT
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock TermsCHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical,
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
GlobeNewswire Inc.
Jan 07, 2025 2:00 PM GMT
Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifec